Anxiolytics and Antipsychotics Flashcards
What are the 3 most common anxiety disorders?
Generalized anxiety disorder (GAD)
Panic disorder (PD)
Social anxiety disorder (SAD)
What is the first line therapy for tx of anxiety disorders?
SSRI and SNRIs
- Fear or anxiety about
social situations
– Concern regarding scrutiny
from others
– Concern regarding
humiliation
embarrassment
– Fear of rejection
– Concern regarding
offending others
Social anxiety disorder
- Recurrent panic attacks
– Shortness of breath
– Dizziness or faintness
– Palpitations
– Sweating
– Trembling or shaking
– Nausea
– Dizziness
– Paresthesias
– Hot flashes or chills
– Chest pain
– Feelings of choking
– Discomfort or fear
Panic disorder
- Excessive anxiety or worry
- Muscle tension
- Restlessness
- Fatigue
- Impaired Concentration
- Irritability
- Insomnia
Generalized anxiety disorder
What 2 drugs (antidepressants) have DDIs that decrease effectiveness of pain meds/opiods?
Fluoxetine
Paroxetine
- FDA approved uses
include postherpetic
neuralgia, neuropathic
pain due to diabetic
peripheral neuropathy
and spinal cord injury,
seizures, and fibromyalgia - Considered a first-line
agent in treatment
guidelines for GAD
– NO FDA approval for GAD
– as effective as SSRI/SNRI
and BZD - MOA - unknown
- Common side effects:
dizziness, sedation,
ataxia, blurred vision, and
weight gain - No life-threatening side
effects - No oral side effects
- “Safe” in overdose
- Low risk for drug
interactions
Pregabalin
- FDA approved uses
include postherpetic
neuralgia and seizures - Used off-label for
anxiety – both
scheduled and prn - Limited evidence for
use in anxiety - MOA - unknown
- Common Side Effects
– Dizziness, sedation and
ataxia - No life-threatening side
effects - No oral side effects
- “Safe” in overdose
- Low risk for drug
interactions
Gabapentin
- Mechanism of Action
– 5-HT1A partial agonist - Uses
– FDA approval for GAD (not recommend as first line
therapy)
– Used as adjunctive therapy with an antidepressant for
treatment refractory depression - NO abuse or withdrawal potential
- Onset of action 4-6 weeks
- Safe in overdose situations
- Low risk for drug interactions
Few side effects
No oral effects
Buspirone
- FDA approved uses
include HTN, angina
pectoris, atria; fibrillation,
myocardial infarction,
migraine prophylaxis,
essential tremor,
hypertrophic subaortic
stenosis,
pheochromocytoma - Used off-label for
“performance” anxiety - MOA - nonselective beta-
adrenergic receptor
blocking agent - Common Side Effects
– Dizziness, weakness and
fatigue - No life-threatening side
effects - No oral side effects
- Overdose –
hypotension and
bradycardia - High risk for drug
interactions
Propranolol
How do BZDs work?
Increase CL channel which decreases GABA binding
DA track:
EP system - movement
Nigrostriatal
DA track:
Arousal, memory, motivation
Mesolimbic
DA track:
Cognition, communication, social function, response to stress
Mesocortical
DA track:
Regulates prolactin release
Tuberinfundibular